Abu Dhabi University (ADU) has made significant strides in enriching the UAE’s healthcare and research landscape with the inauguration of the Abu Dhabi University Cancer Research Institute (ADU-CRI). This forward-thinking institute is designed to facilitate cutting-edge cancer research and personalised treatment methodologies, representing a pivotal advancement for both academic and medical fields within the nation.
The launch event, hosted at ADU’s Innovation Center, was attended by senior figures from the university, representatives from the Department of Health – Abu Dhabi, as well as key players from healthcare and research sectors. This initiative aligns with ADU’s commitment to promoting scientific innovation and education, resonating with the national goals outlined in the We the UAE 2031 vision.
With the establishment of ADU-CRI, the university seeks to position itself as a prominent hub for cancer research that bridges educational insight with practical clinical applications. The focus is on translational research, ensuring that scientific breakthroughs are rapidly transitioned from laboratories to hospitals and clinical care. Collaboration is central to this initiative, as it unites researchers, healthcare professionals, government entities, and industry stakeholders to tackle the pressing cancer challenges within the region.
ADU-CRI comprises five dedicated research divisions, including genomics and bioinformatics, biomarker investigation, drug discovery, bioengineering, and public health research. Each division aims at a crucial element of cancer prevention, diagnosis, and treatment, fostering a comprehensive, multidisciplinary research framework.
The institute is outfitted with state-of-the-art laboratory technologies such as flow cytometry, Luminex systems, quantitative PCR, sequencing platforms, and advanced tissue culture facilities. These tools empower researchers to engage in both preclinical and clinical studies, particularly addressing cancer priority areas identified by UAE health authorities. A specialized bioengineering lab also enhances research efforts related to biosensor innovation, data analytics, and next-gen medical inquiries.
ADU-CRI has forged robust partnerships with leading healthcare and research organizations throughout Abu Dhabi. These collaborations have catalyzed numerous ongoing projects, including clinical studies aimed at enhancing breast cancer diagnosis and treatment, efforts leveraging biobanked samples for advanced research, and explorations of novel strategies in personalized cancer care.
Current research initiatives at the institute encompass studies on biomarkers linked to triple-negative breast cancer, liquid biopsy methods for early lung cancer detection, and investigations into genetic factors associated with cancer metastasis. Collectively, these projects aim to advance early diagnostic procedures, refine treatment accuracy, and bolster evidence-based healthcare strategies within the UAE.
The introduction of ADU-CRI underscores Abu Dhabi University’s expanding influence in the realm of national healthcare through innovative research. By melding advanced facilities, strategic collaborations, and research tailored to regional needs, the institute is poised to make significant contributions to cancer care and long-term progress within the UAE’s life sciences sector.
Federal government signs landmark agreements with Musqueam Nation, recognizing Aboriginal rights whi
Canada’s labour market faltered with a sharp drop in employment and higher unemployment, marking the
Samuel Ramirez Jr., added to FBI’s Ten Most Wanted, was captured in Mexico just 73 minutes after lis
A US federal judge dismissed subpoenas targeting Federal Reserve chair Jerome Powell, saying prosecu
